Korsana Biosciences, Inc. (KRSA)
31.05
+0.62
(+2.04%)
USD |
NASDAQ |
Nov 06, 16:00
31.42
+0.37
(+1.19%)
After-Hours: 20:00
Korsana Biosciences Total Long Term Debt (Quarterly) : 0.984M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.984M |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 38.07M |
| December 31, 2020 | 38.93M |
| September 30, 2020 | 39.79M |
| June 30, 2020 | 46.29M |
| March 31, 2020 | 47.06M |
| December 31, 2019 | 70.50M |
| September 30, 2019 | 71.41M |
| June 30, 2019 | 72.40M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Q32 Bio, Inc. | 4.364M |
| IRulya Therapeutics, Inc. | 0.00 |
| Climb Bio, Inc. | 0.605M |
| PepGen Inc. | 12.86M |
| Bridgebio Oncology Therapeutics, Inc. | 1.96M |